Chanoch Miodownik

1.6k total citations
43 papers, 1.1k citations indexed

About

Chanoch Miodownik is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, Chanoch Miodownik has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 15 papers in Neurology and 7 papers in Physiology. Recurrent topics in Chanoch Miodownik's work include Schizophrenia research and treatment (13 papers), Electroconvulsive Therapy Studies (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Chanoch Miodownik is often cited by papers focused on Schizophrenia research and treatment (13 papers), Electroconvulsive Therapy Studies (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Chanoch Miodownik collaborates with scholars based in Israel, Russia and United States. Chanoch Miodownik's co-authors include Vladimir Lerner, Joseph Bergman, Moshe Kotler, Yuly Bersudsky, Anatoly Kreinin, Michael S. Ritsner, Carol D. Austin, Avi Bleich, Joseph Zohar and Roger Lane and has published in prestigious journals such as American Journal of Psychiatry, The Journal of Clinical Psychiatry and Clinical Nutrition.

In The Last Decade

Chanoch Miodownik

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chanoch Miodownik Israel 20 402 317 191 168 135 43 1.1k
Jonathan G. Leung United States 15 339 0.8× 258 0.8× 78 0.4× 142 0.8× 52 0.4× 92 1.0k
Holly A. Zboyan United States 10 481 1.2× 249 0.8× 171 0.9× 132 0.8× 112 0.8× 12 1.4k
L. Pepplinkhuizen Netherlands 22 309 0.8× 68 0.2× 120 0.6× 164 1.0× 158 1.2× 65 1.3k
A. Mechri Tunisia 17 612 1.5× 105 0.3× 176 0.9× 465 2.8× 138 1.0× 60 1.5k
Chun-Hsin Chen Taiwan 24 430 1.1× 110 0.3× 91 0.5× 212 1.3× 259 1.9× 53 1.3k
Boris Nemets Israel 13 284 0.7× 167 0.5× 218 1.1× 139 0.8× 85 0.6× 23 1.2k
Jolanta Rabe‐Jabłońska Poland 17 332 0.8× 48 0.2× 139 0.7× 210 1.3× 86 0.6× 98 987
Alessandra Frustaci Italy 17 323 0.8× 87 0.3× 159 0.8× 84 0.5× 203 1.5× 22 1.0k
Ninoslav Mimica Croatia 20 313 0.8× 73 0.2× 140 0.7× 132 0.8× 148 1.1× 141 1.1k
Chieh‐Liang Huang Taiwan 15 351 0.9× 56 0.2× 87 0.5× 215 1.3× 216 1.6× 36 1.2k

Countries citing papers authored by Chanoch Miodownik

Since Specialization
Citations

This map shows the geographic impact of Chanoch Miodownik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chanoch Miodownik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chanoch Miodownik more than expected).

Fields of papers citing papers by Chanoch Miodownik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chanoch Miodownik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chanoch Miodownik. The network helps show where Chanoch Miodownik may publish in the future.

Co-authorship network of co-authors of Chanoch Miodownik

This figure shows the co-authorship network connecting the top 25 collaborators of Chanoch Miodownik. A scholar is included among the top collaborators of Chanoch Miodownik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chanoch Miodownik. Chanoch Miodownik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miodownik, Chanoch, et al.. (2023). Treatment of Clozapine-Associated Sialorrhea. Journal of Clinical Psychopharmacology. 43(2). 171–177. 5 indexed citations
2.
Miodownik, Chanoch, et al.. (2019). Clinical and demographic characteristics of secluded and mechanically restrained mentally ill patients: a retrospective study. Israel Journal of Health Policy Research. 8(1). 9–9. 15 indexed citations
3.
Miodownik, Chanoch, et al.. (2016). Association Between Vitamin D Serum Level and Depression. 5(1). 4–12. 3 indexed citations
4.
Kreinin, Anatoly, et al.. (2016). Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine. Journal of Clinical Psychopharmacology. 36(3). 200–205. 13 indexed citations
5.
Miodownik, Chanoch, et al.. (2015). Amisulpride as Add-on Treatment for Resistant Obsessive-Compulsive Disorder. Clinical Neuropharmacology. 38(1). 26–29. 6 indexed citations
6.
Bergman, Joseph, et al.. (2013). Curcumin as an Add-On to Antidepressive Treatment. Clinical Neuropharmacology. 36(3). 73–77. 68 indexed citations
7.
Lerner, Vladimir, et al.. (2013). The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia. The Journal of Clinical Psychiatry. 74(12). 1224–1232. 43 indexed citations
8.
Bergman, Joseph, et al.. (2011). Efficacy of Bupropion XR in Treatment-Resistant Elderly Patients. Clinical Neuropharmacology. 34(1). 17–20. 6 indexed citations
9.
Lerner, Vladimir, et al.. (2008). Bexarotene as Add-On to Antipsychotic Treatment in Schizophrenia Patients. Clinical Neuropharmacology. 31(1). 25–33. 33 indexed citations
10.
Miodownik, Chanoch, et al.. (2008). Pyridoxal Plasma Level in Schizophrenic and Schizoaffective Patients With and Without Tardive Dyskinesia. Clinical Neuropharmacology. 31(4). 197–203. 6 indexed citations
11.
Lerner, Vladimir & Chanoch Miodownik. (2007). Vitamin B6 Treatment for Tardive Dyskinesia. The Journal of Clinical Psychiatry. 68(11). 1648–1654. 58 indexed citations
12.
Miodownik, Chanoch, Vladimir Lerner, Tali Vishne, Ben‐Ami Sela, & Joseph Levine. (2007). High-dose Vitamin B6 Decreases Homocysteine Serum Levels in Patients With Schizophrenia and Schizoaffective Disorders. Clinical Neuropharmacology. 30(1). 13–17. 17 indexed citations
13.
Miodownik, Chanoch, et al.. (2007). Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients. The Journal of Clinical Psychiatry. 68(7). 1031–1037. 42 indexed citations
14.
Miodownik, Chanoch, et al.. (2006). Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia. Clinical Neuropharmacology. 29(2). 68–72. 32 indexed citations
15.
Lerner, Vladimir, et al.. (2005). High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia. The Journal of Clinical Psychiatry. 66(12). 1558–1563. 15 indexed citations
16.
Lerner, Vladimir, et al.. (2005). Augmentation With Amisulpride for Schizophrenic Patients Nonresponsive to Antipsychotic Monotherapy. Clinical Neuropharmacology. 28(2). 66–71. 21 indexed citations
17.
Lerner, Vladimir, et al.. (2005). Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clinical Nutrition. 25(1). 60–67. 40 indexed citations
18.
Lerner, Vladimir, Chanoch Miodownik, Hagit Cohen, et al.. (2001). Vitamin B6 in the Treatment of Tardive Dyskinesia: A Double-Blind, Placebo-Controlled, Crossover Study. American Journal of Psychiatry. 158(9). 1511–1514. 53 indexed citations
19.
Miodownik, Chanoch & Vladimir Lerner. (2000). Risperidone in the Treatment of Psychotic Depression. Clinical Neuropharmacology. 23(6). 335–337. 10 indexed citations
20.
Miodownik, Chanoch, Vladimir Lerner, Hagit Cohen, & Moshe Kotler. (2000). Serum Vitamin B6 in Schizophrenic and Schizoaffective Patients with and without Tardive Dyskinesia. Clinical Neuropharmacology. 23(4). 212–215. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan G. Leung Breakdown of academic impact, for papers by Holly A. Zboyan Breakdown of academic impact, for papers by L. Pepplinkhuizen Breakdown of academic impact, for papers by A. Mechri Breakdown of academic impact, for papers by Chun-Hsin Chen Breakdown of academic impact, for papers by Boris Nemets Breakdown of academic impact, for papers by Jolanta Rabe‐Jabłońska Breakdown of academic impact, for papers by Alessandra Frustaci Breakdown of academic impact, for papers by Ninoslav Mimica Breakdown of academic impact, for papers by Chieh‐Liang Huang
Rankless by CCL
2026